ReviewFrontiers in endocrinology2025
Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer.
Tanaya A Purohit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it